Indietro

Oral Communication

Tailored approaches to antiretroviral therapy

OC 34
Clinical outcome of switching to a dual drug regimen (2DR) vs. switching or remaining on a triple (3DR) regimen in the setting of a viral load ≤50 copies/mL
Abstract
OC 35
Cumulative risk of discontinuation of modern first-line ART by reason for stopping and type of ART initiated: findings from the ICONA cohort
Abstract
OC 36
CD4 T-cell, CD4/CD8 ratio improvement and a general reduction in inflammatory biomarkers with low level viremia (LLV) up to Week 192 with Fostemsavir (FTR) based regimens in individuals with multidrug-resistant (MDR) HIV-1
Abstract
OC 37
Well-being in people with HIV after one year of long-acting cabotegravir and rilpivirine
Abstract
| Privacy policy | Cookies policy | Termini e condizioni di utilizzo |
© Effetti srl
P. IVA 10756900154
×

Commento audio

Chiudi